Researchers Discovery Genome Editing With DNAitton Genome Editing At iQome Research Institute
CHICAGO Researchers from University of California San Diego have discovered DNAitton DNAix a gene editing tool that can be used by clinicians to predict chromosomal abnormalities and treat diseases.
Idencnix is a gene-editing tool that enables clinicians to interpret genetic changes as signs of disease helping them take decisive action in a fading patient. It has been used by more than 3 million people worldwide including nearly 80000 in 10 clinical trials.
Using genome editing could provide a valuable tool for diagnosis and treatment of special health conditions including cancer heart disease diabetes and brain injury said lead author Maria Barbra Vega-Ozumi MD PhD professor in the Department of Pathology at UC San Diego School of Medicine and San Diego Division of Translational Medicine.
Gene editing using DNAitton DNAix is a widely used approach in the genomic editing tool-triggered by technology called CRISPRCas9 gene editing said first author of the study Michael Full Chain MD Ph. D. assistant professor in the Department of Genetics UCSF.din. Its an all-or-none approach with the most versatility. Several genes can be programmed to add axon segments to chromosomes which are pushing or pulling DNA out of chromosomes. Vega-Ozumi and Full have said DNAitton DNAix can aid in identifying chromosomal abnormal cells and potentially being used cheaply in diagnostic means. Non-pathogenic DNA segments can be created by adding RNA tags a chemical tagging process to one end of chromosomes to disrupt genes.